Ethanol, 2-[(3-nitropyrazolo[1,5-a]pyridin-2-yl)oxy]-

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From 6 October 2014 to 18 December 2014

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Well described study performed according to OECD guideline and GLP

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2014

Report date:

2014

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)

Deviations:

no

Test guideline 3

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)

Deviations:

not specified

GLP compliance:

yes (incl. QA statement)

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

2-[(3-nitropyrazolo[1,5-a] pyridine-2-yl)oxyethanol

IUPAC Name:

2-[(3-nitropyrazolo[1,5-a] pyridine-2-yl)oxyethanol

Constituent 2

Reference substance name:

R0056895A

IUPAC Name:

R0056895A

Test material form:

solid: particulate/powder

Remarks:

migrated information: powder

Method

Species / strain

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Metabolic activation system:

post mitochondrial supernatant prepared from the livers of phenobarbital/b-naphthoflavone-induced rats.

Test concentrations with justification for top dose:

5000, 2500, 1250, 625, 312.5, 156.25, 78.13 and 39.06 μg/plate.

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: DMF (N,N-Dimethylformamide)
- Justification for choice of solvent/vehicle: based on the results of a solubility test

Controls

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

True negative controls:

yes

Positive controls:

yes

Positive control substance:

9-aminoacridine

sodium azide

methylmethanesulfonate

other: 4-nitro-1,2-phenylenediamine (NPD), 2-aminoanthracene

Details on test system and experimental conditions:

METHOD OF APPLICATION: in agar (plate incorporation) for the initial test; preincubation in the confirmatory test

DURATION
- Preincubation period: 20 minutes (confirmatory tests)
- Exposure duration: 48±1 hours

NUMBER OF REPLICATES: 3 per dose level

DETERMINATION OF CYTOTOXICITY
- Method: relative total growth

Evaluation criteria:

Criteria for a Positive Response:
The test item was considered to have shown mutagenic activity in this study if a 2-fold increase (in S. typhimurium TA98, TA100 and E. coli WP2 uvrA strains) or 3-fold increase (in S. typhimurium TA1535 and TA1537 strains) in the mean number of revertants was observed when compared to the vehicle (solvent) controls, in any strain, with an evidence of a dose-response relationship.
Criteria for a Negative Response:
The test item was considered to have shown no mutagenic activity in this study if no increase in the mean number of revertants, reaching 2-fold (for S. typhimurium TA98, TA100 and E. coli WP2 uvrA strains) or 3-fold (for S. TA1535 and TA1537 strains) of the vehicle controls value, was observed at any of the tested dose-levels.
Reference to historical data or other considerations of biological relevance might be taken into account in the evaluation of the data obtained.
Statistical method may be used as an aid in evaluating the test results.

Results and discussion

Test results

Species / strain:

S. typhimurium TA 98

Metabolic activation:

with and without

Genotoxicity:

positive

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

see details below

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

TEST-SPECIFIC CONFOUNDING FACTORS
No insolubility was detected in the main tests in any examined bacterial strains with and without metabolic activation.

RANGE-FINDING/SCREENING STUDIES:
In the Preliminary Range Finding Test, substantial increases of the revertant counts were observed in Salmonella typhimurium TA98 bacterial strain with and without metabolic activation. The calculated mutation factor values were over the relevant threshold value in this strain in several cases, dose dependence was also observed.
No precipitate was detected on the plates in the preliminary experiment in Salmonella typhimurium TA98 bacterial strain with and without metabolic activation.
No signs of inhibitory, cytotoxic effects were observed in the preliminary experiment in Salmonella typhimurium TA98 bacterial strain at any concentrations with or without metabolic activation.

COMPARISON WITH HISTORICAL CONTROL DATA:
The mean values of revertant colony numbers of untreated, negative (vehicle/solvent) and positive control plates were in harmony with the historical control range in all strains.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
Inhibitory, cytotoxic effect of the test item (slightly reduced background lawn development, reduced number of revertant colonies was also detected in some cases) was observed in the Confirmatory Mutation Test in Salmonella typhimurium TA1537 strain at 5000 μg/plate concentration with and without metabolic activation.

Any other information on results incl. tables

Table 1: Summary Table of the Initial Mutation Test (Mean values of revertants)

Concentrations (µg/plate)	Salmonella typhimuriumstrains								Escherichia coli
	TA98		TA100		TA1535		TA1537		WP2uvrA
	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9
Untreated control	24.0	25.7	107.7	108.0	11.7	11.7	10.7	11.3	77.3	66.3
Distilled water control	-	-	87.3	-	13.0	-	-	-	78.0	-
DMSO control	21.3	35.7	-	97.3	-	9.7	14.7	11.3	-	68.0
DMF control	17.3	28.3	81.7	94.0	15.0	10.7	14.0	10.3	85.0	66.7
5000	486.7	510.7	116.3	108.0	9.0	9.3	16.7	12.0	55.3	71.3
2500	313.3	348.0	104.3	100.3	11.7	9.3	13.7	11.3	63.7	61.7
1250	207.3	221.3	105.3	109.0	15.7	7.0	16.3	16.0	73.3	73.7
625	126.7	133.3	102.0	103.0	18.3	13.0	15.3	15.0	76.0	71.7
312.5	64.3	96.3	83.7	103.3	15.7	12.0	16.0	15.3	66.0	67.7
156.25	47.0	56.3	92.7	105.3	14.3	11.3	15.3	12.3	74.7	69.3
78.13	26.3	43.0	85.0	98.7	13.3	12.3	13.0	15.0	78.0	71.7
39.06	23.7	40.3	93.0	85.3	16.0	12.0	10.0	10.7	110.0	77.3
NPD (4µg)	392.0	-	-	-	-	-	-	-	-	-
2AA (2µg)	-	2521.3	-	2393.3	-	190.3	-	196.7	-	-
2AA (50µg)	-	-	-	-	-	-	-	-	-	309.7
SAZ (2µg)	-	-	1093.3	-	1084.0	-	-	-	-	-
9AA (50µg)	-	-	-	-	-	-	390.7	-	-	-
MMS (2µL)	-	-	-	-	-	-	-	-	1121.3	-

Table 2: Summary Table of the Confirmatory Mutation Test (Mean values of revertants)

Concentrations (µg/plate)	Salmonella typhimuriumstrains								Escherichia coli
	TA98		TA100		TA1535		TA1537		WP2uvrA
	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9	-S9	+S9
Untreated control	17.0	26.0	100.3	104.0	12.0	7.3	4.0	11.7	30.7	41.7
Distilled water control	-	-	98.0	-	14.0	-	-	-	31.3	-
DMSO control	21.0	27.3	-	94.3	-	11.0	3.7	7.0	-	31.7
DMF control	24.3	32.7	91.0	100.0	18.7	9.0	6.3	7.0	27.0	32.7
5000	488.0	341.3	102.3	116.0	8.7	10.3	4.7	0.3	28.7	29.7
2500	774.7	335.3	106.3	104.3	11.0	11.7	9.3	4.3	38.7	43.0
1250	214.7	272.0	88.3	99.7	12.0	11.0	7.7	14.3	49.3	52.7
625	157.0	183.7	103.7	97.3	15.0	9.7	9.7	12.7	48.0	59.3
312.5	89.7	104.3	101.3	111.3	17.3	7.7	7.7	8.7	51.0	58.7
156.25	52.7	71.7	103.3	105.7	12.3	11.0	7.0	7.0	52.3	56.3
78.13	34.3	47.0	93.3	100.3	19.0	9.3	8.0	9.7	53.0	60.7
39.06	29.7	48.7	105.0	108.3	12.7	8.0	10.7	9.7	44.0	44.7
NPD (4µg)	362.3	-	-	-	-	-	-	-	-	-
2AA (2µg)	-	2328.0	-	2406.7	-	315.7	-	193.3	-	-
2AA (50µg)	-	-	-	-	-	-	-	-	-	247.7
SAZ (2µg)	-	-	1194.7	-	1198.7	-	-	-	-	-
9AA (50µg)	-	-	-	-	-	-	385.3	-	-	-
MMS (2µL)	-	-	-	-	-	-	-	-	896.0	-

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
positive without and without metabolic activation (in S. typhimurium TA 98)
negative all other strains with and without metabolic activation

R0056895A had mutagenic activity in Salmonella typhimurium TA98 strain in the presence and absence of metabolic activation system. However, no mutagenic activity of the test item was observed in the other four experimental strains under the test conditions of this study. Based on these data, the overall result is positive.

Executive summary:

R005895A was tested for potential mutagenic activity using the Bacterial Reverse Mutation Assay, based on OECD Guidelines for Testing of Chemicals, No.471 and Commission Regulation (EC) No. 440/2008, B.13/14. with Salmonella typhimurium TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2 uvrA, in the presence and absence of a post mitochondrial supernatant (S9 fraction) prepared from the livers of phenobarbital/b-naphthoflavone-induced rats. R0058407A was tested up to 5000 µg/plate in DMF.

R0056895A had mutagenic activity in Salmonella typhimurium TA98 strain in the presence and absence of metabolic activation system. However, no mutagenic activity of the test item was observed in the other four experimental strains under the test conditions of this study.

Based on these data, the overall result is positive.